Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia

Biochemical and Biophysical Research Communications

Volumn 341, Issue 4, 2006, Pages 1066-1071

  Zhao, Tieqiang ^a,b   Guo, Jun ^c   Li, Hui ^a,b   Huang, Wei ^a,b   Xian, Xunde ^a,b   Ross, Colin J D ^d   Hayden, Michael R ^d   Wen, Zongyao ^c   Liu, George ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c PEKING UNIVERSITY   (China)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Hemorheology; Hypertriglyceridemia; Lipoprotein lipase

Indexed keywords

CHOLESTEROL; LIPOPROTEIN LIPASE; MEMBRANE LIPID; PHOSPHOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROPHORESIS; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE DISORDER; ERYTHROCYTE FRAGILITY; ERYTHROCYTE LEVEL; ERYTHROCYTE MEMBRANE; ERYTHROCYTE STRUCTURE; EXPERIMENTAL MODEL; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; MEMBRANE FLUIDITY; MOUSE; MOUSE STRAIN; NONHUMAN; OSMOTIC FRAGILITY; PANCREATITIS; PATHOGENESIS; PLASMA VISCOSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ANIMALS; BLOOD VISCOSITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMORHEOLOGY; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MEMBRANE LIPIDS; MICE; OSMOTIC FRAGILITY;

ANIMALIA;

EID: 32344446163     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.01.067     Document Type: Article

References (35)

1. W.H. Capell, K.P. Spiegelman, and R.H. Eckel Therapeutic targets in severe hypertriglyceridemia Drug Discov. Today 1 2004 171 177
2. P.P. Toskes Hyperlipidemic pancreatitis Gastroenterol. Clin. North Am. 19 1990 783 791
3. H.N. Ginsberg New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism Circulation 106 2002 2137 2142
4. J.S. Forrester Triglycerides: risk factor or fellow traveler? Curr. Opin. Cardiol. 16 2001 261 264
5. P. Benlian, J.L. De Gennes, L. Foubert, H. Zhang, S.E. Gagne, and M. Hayden Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene N. Engl. J. Med. 335 1996 848 854
6. A. Hauenschild, H. Schnell-Kretschmer, and H.U. Kloer Severe hypertriglyceridemia (SHTG) and atherosclerosis Atherosclerosis 151 2000 177
7. R.J. Havel, and R.S. Gordon Jr. Idiopathic hyperlipemia: metabolic studies in an affected family J. Clin. Invest. 39 1960 1777 1790
8. R.S. Lees, D.E. Wilson, G. Schonfeld, and S. Fleet The familial dyslipoproteinemias A.G. Steinberg A.G. Bearn Progress in Medical Genetics vol. 9 1973 Grune and Stratton New York 237 290
9. J.H. Stein, and R.S. Rosenson Treatment of severe HTG lowers plasma viscosity Atherosclerosis 137 1998 401 405
10. C. Otto, M.M. Ritter, W.O. Richter, R. Minkenberg, and P. Schwandt Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks Metabolism 50 2001 166 170
11. L.N. Peritz, J.D. Brunzell, C. Harvey-Clarke, P.H. PriChhard, B.R. Jones, and M.R. Hayden Characterization of a lipoprotein lipase class III type defect in hypertriglyceridemic cats Clin. Invest. Med. 13 1990 259 263
12. R. Savonen, K. Nordstoga, B. Christophersen, A. Lindberg, Y. Shen, M. Hultin, T. Olivecrona, and G. Olivecrona Chylomicron metabolism in an animal model for hyperlipoproteinemia type I J. Lipid Res. 40 1999 1336 1346
13. K. Conde-Knape, A. Bensadoun, J.H. Sobel, J.S. Cohn, and N.S. Shachter Overexpression of apoC-Iin apoE-null mice: severe HTG due to inhibition of hepatic lipase J. Lipid Res. 43 2002 2136 2145
14. T. Ebara, R. Ramakrishnan, G. Steiner, and N.S. Shachter Chylomicronemia due to Apolipoprotein C-III overexpression in Apolipoprotein E-null mice. Apolipoprotein CIII-induced HTG is not mediated by effects on Apolipoprotein E J. Clin. Invest. 99 1997 2672 2681
15. C.J. Ross, J. Twisk, J.M. Meulenberg, G. Liu, K. van den Oever, E. Moraal, W.T. Hermens, J. Rip, J.J. Kastelein, J.A. Kuivenhoven, and M.R. Hayden Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation Hum. Gene Ther. 15 2004 906 919
16. C.J. Ross, G. Liu, J.A. Kuivenhoven, J. Twisk, J. Rip, w. Van Dop, k.J. Ashbourne Excoffon, S.M. Lewis, J.J. Kastelein, and M.R. Hayden Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation Arterioscler. Thromb. Vasc. Biol. 25 2005 2143 2150
17. Z.Y. Wen, Z.Y. Yan, T. Gao, H.F. Dou, J.F. Lu, D.G. Sun, and Z.H. Lu A study of effects of WGA and ConA on RBC membrane receptors using a new ektacytometric method Clin. Heomrheol. Microcirc. 17 1997 467 478
18. M.L.G. Bautista, W. Altaf, R. Lall, and R.A. Wapnir Cord blood red cell osmotic fragility: a comparison between preterm and full-term newborn infants Early Hum. Dev. 72 2003 37 46
19. T. Azumi, and S.P. McGlynn Polarization of the luminescence of phenanthrene J. Chem. Phys. 37 1962 2413 2420
20. J. Folch, M. Lees, and G.H. Sloane Stanley A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 1957 497 509
21. R.S. Rosenson, S. Shott, and C.C. Tangney HTG is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity Atherosclerosis 161 2002 433 439
22. R.S. Rosenson, and G.D. Lowe Effects of lipids and lipoproteins on thrombosis and rheology Atherosclerosis 140 1998 271 280
23. A.H. Seplowitz, S. Chien, and F.R. Smith Effects of lipoproteins on plasma viscosity Atherosclerosis 38 1981 89 95
24. H. Leonhardt, H.R. Arntz, and U.H. Klemens Studies of plasma viscosity in primary hyperlipoproteinaemia Atherosclerosis 28 1977 29 40
25. G.D. Lowe, D.A. Wood, J.T. Douglas, R.A. Riemersma, C.C. Macintyre, T. Takase, E.G. Tuddenham, C.D. Forbes, R.A. Elton, and M.F. Oliver Relationships of plasma viscosity coagulation and fibrinolysis to coronary risk factors and angina Thromb. Haemost. 65 1991 339 343
26. Z.Y. Wen, Z.L. Tao, W.Y. Ma, and D.G. Sun The influence of surface charge of RBC membrane upon its orientation in a shear flow field of low viscosity Clin. Hemorheol. 14 1994 279 283
27. Z.Y. Wen, Z.L. Tao, S. Cao, and Y.H. Zhao Can we use PBS as an alternative to dextran in ektacytometric measurement? Clin. Hemorheol. 11 1991 459 464
28. W.J. Yao, Z.Y. Wen, Z.Y. Yan, D.G. Sun, W.B. Ka, L.D. Xie, and S. Chien Low viscosity ektacytometry and its validation tested by flow chamber J. Biomech. 34 2001 1501 1509
29. S. Chien, S. Usami, R.J. Dellenback, and M.I. Gregersen Shear dependent interactions of plasma protein with erythrocytes in blood Am. J. Physiol. 219 1970 143 148
30. I. Cicha, Y. Suzuki, N. Tateishi, and N. Maeda Effects of dietary triglycerides on rheological properties of human red blood cells Clin. Heomrheol. Microcirc. 30 2004 301 305
31. M. Labios, M. Martinez, A. Vaya, F. Gabriel, V. Guiral, and J. Aznar Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients Clin. Heomrheol. Microcirc. 21 1999 79 85
32. G.N. Hernandez, C. Dabin, M. del, C. Gayol, and M.L. Rasia Haemorheological variable in a rat model of hypertriglyceridaemic obesity and diabetes Vet. Res. Commun. 26 2002 625 635
33. D. Yadav, and C.S. PiChhumoni Issues in hyperlipidemic pancreatitis J. Clin. Gastroenterol. 36 2003 54 62
34. J.W.G. Yarnell, I.A. Baker, P.M. Sweetnam, D. Bainton, J.R. O'Brien, P.J. Whitehead, and P.C. Elwood Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease Circulation 83 1991 836 844
35. R.S. Rosenson Viscosity and ischemic heart disease J. Vasc. Med. Biol. 4 1993 206 212